{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:37:20Z","timestamp":1777365440636,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":1622,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1136\/ijgc-2020-001379","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T06:54:40Z","timestamp":1594882480000},"page":"1089-1094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6260-5353","authenticated-orcid":false,"given":"Dimitrios","family":"Nasioudis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison Grace","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily M","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Cory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L","family":"Giuntoli II","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley F","family":"Haggerty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah H","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawar A","family":"Latif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001379_bb0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/AOG.0b013e3182605bf1","article-title":"Endometrial cancer","volume":"120","author":"Sorosky","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001379_bb0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2009.06.011","article-title":"Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review","volume":"115","author":"Boruta","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001379_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers11111665","article-title":"Unique molecular features in high-risk histology endometrial cancers","volume":"11","author":"Pandita","year":"2019","journal-title":"Cancers"},{"key":"10.1136\/ijgc-2020-001379_bb0025","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.24247","article-title":"Platinum\/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma","volume":"115","author":"Fader","year":"2009","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2020-001379_bb0030","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial","volume":"20","author":"de Boer","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2020-001379_bb0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","article-title":"Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Koh","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1136\/ijgc-2020-001379_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ygyno.2007.05.044","article-title":"Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma","volume":"107","author":"Thomas","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001379_bb0045","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ygyno.2007.01.041","article-title":"Outcomes in surgical stage I uterine papillary serous carcinoma","volume":"105","author":"Havrilesky","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001379_bb0050","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/IGC.0b013e31822e7588","article-title":"Role of adjuvant chemotherapy in patients with early stage uterine papillary serous cancer","volume":"21","author":"Mahdavi","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001379_bb0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2005.06.012","article-title":"Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy","volume":"98","author":"Kelly","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001379_bb0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2013.11.002","article-title":"Population-based treatment and outcomes of stage I uterine serous carcinoma","volume":"132","author":"van der Putten","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001379_bb0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2015.01.544","article-title":"Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study","volume":"137","author":"Mahdi","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001379_bb0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2011.02.040","article-title":"Endometrial cancer in the oldest old: tumor characteristics, patterns of care, and outcome","volume":"122","author":"Wright","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001379_bb0075","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jgo.2013.07.001","article-title":"Surgical treatment of elderly patients with endometrial cancer (\u2265 65 years)","volume":"4","author":"De Marzi","year":"2013","journal-title":"J Geriatr Oncol"},{"key":"10.1136\/ijgc-2020-001379_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ygyno.2009.07.004","article-title":"Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006","volume":"115","author":"Tchabo","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001379_bb0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/IGC.0000000000000635","article-title":"An assessment of prognostic factors, adjuvant treatment, and outcomes of stage Ia polyp-limited versus endometrium-limited type II endometrial carcinoma","volume":"26","author":"Liang","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001379_bb0090","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ygyno.2005.08.037","article-title":"Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group","volume":"100","author":"Sutton","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001379_bb0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2003.08.027","article-title":"Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy","volume":"91","author":"Huh","year":"2003","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:25:56Z","timestamp":1753233956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1048891X25000544"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001379","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}